Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

PSB and Farminerva collaborate to develop diagnostics and new therapeutic in peptide based biopharmaceuticals

14.11.2006
Fondazione Parco Biomedico San Raffaele and a new Lazio based biotechnology firm, Farminerva S.r.l. have signed an agreement to collaborate on the development of novel biopharmaceutical peptide based diagnostics and therapeutics.

The collaboration will involve the permanent presence of a Farminerva S.r.l. section on the science park, and will join two other biotechnology companies present there (LayLine Genomics and BioLab). Effort will be dedicated to accelerating domestic and international partnerships to in-license or co-develop new intellectual property with the aim to move the development as far as possible up the biomedical product value chain, prior to out-licensing for significant value creations.

Fondazione Parco Biomedico San Raffaele (PSB)

Located approximately 15 km south of Rome in a natural reserve, the science park was created by the Banca di Roma, the Chamber of Commerce of Rome, and the Fondazione San Raffaele Monte Tabor in response to the recognised need to have a biomedical research centre in the Lazio region. Opened in 2002, the park is now home to 3 companies and 9 research groups from Universities and centres working in: Stem cells, Oncology, leukaemia and Immunology; Molecular cardiology; Skeletal regeneration; Cell therapy and tissue engineering; Muscular dystrophies; Biomedical quality control; Neurological Disorders and Diabetes. The infrastructure permits the development of concept to preclinical development based on the state-of-the-art facilities including a animal facility encompassing conventional and SPF small animals and a large animal surgery unit.

... more about:
»Development »Farminerva »therapeutic

Farminerva

Farminerva is a private company, founded in 2006, focused on research activities to reach new advanced solutions in biomedical sector. These objectives are developed by a strong cooperation with academic and institutional centres, as the Fondazione Parco Biomedico San Raffaele and CRISC of the Rome University, where Farminerva sponsors the execution of all preclinical and clinical studies requested by local regulatory authorities to obtain marketing license.

This collaboration defines a platform which promotes and coordinates research projects from preclinical to clinical phases to improve specific knowledge in two particular field: the first one concerns new products useful in early diagnosis of orthopaedic, cardiovascular, bone tissue inflammatory and/or infective based diseases, diabetic and oncological diseases. Further effort will be targeted on developing drugs for treatment of infective, diabetic and oncological diseases.

The other one aims to discovery new therapeutic indication of generic drugs to treat neurological, psychiatric and abuse disorders (second/other medical use), through the participation of CNR IASI researchers which perform advanced statistical analysis on large database (1/3 million of subjects) to identify co-morbidity data of relevant clinic interest.

About 50 free lance professionals work in Farminerva projects to ensure high quality level in management and monitoring activities and significantly shorter time to achieve the marketing phase.

Jonathan Dando | alfa
Further information:
http://www.scienceparkrome.org

Further reports about: Development Farminerva therapeutic

More articles from Life Sciences:

nachricht Researchers identify potentially druggable mutant p53 proteins that promote cancer growth
09.12.2016 | Cold Spring Harbor Laboratory

nachricht Plant-based substance boosts eyelash growth
09.12.2016 | Fraunhofer-Institut für Angewandte Polymerforschung IAP

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>